287 related articles for article (PubMed ID: 26404249)
1. Role of RUNX2 in Breast Carcinogenesis.
Wysokinski D; Blasiak J; Pawlowska E
Int J Mol Sci; 2015 Sep; 16(9):20969-93. PubMed ID: 26404249
[TBL] [Abstract][Full Text] [Related]
2. Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform.
Kammerer M; Gutzwiller S; Stauffer D; Delhon I; Seltenmeyer Y; Fournier B
Mol Cell Endocrinol; 2013 Apr; 369(1-2):150-60. PubMed ID: 23403054
[TBL] [Abstract][Full Text] [Related]
3. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.
Khalid O; Baniwal SK; Purcell DJ; Leclerc N; Gabet Y; Stallcup MR; Coetzee GA; Frenkel B
Endocrinology; 2008 Dec; 149(12):5984-95. PubMed ID: 18755791
[TBL] [Abstract][Full Text] [Related]
5. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
6. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
7. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
[TBL] [Abstract][Full Text] [Related]
8. RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.
Brusgard JL; Choe M; Chumsri S; Renoud K; MacKerell AD; Sudol M; Passaniti A
Oncotarget; 2015 Sep; 6(29):28132-50. PubMed ID: 26320173
[TBL] [Abstract][Full Text] [Related]
9. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
10. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
11. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
12. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
13. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
[TBL] [Abstract][Full Text] [Related]
14. RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization.
Li XQ; Lu JT; Tan CC; Wang QS; Feng YM
Cancer Lett; 2016 Sep; 380(1):78-86. PubMed ID: 27317874
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
16. The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues.
Jeong JH; Jung YK; Kim HJ; Jin JS; Kim HN; Kang SM; Kim SY; van Wijnen AJ; Stein JL; Lian JB; Stein GS; Kato S; Choi JY
Mol Cell Biol; 2010 May; 30(10):2365-75. PubMed ID: 20231365
[TBL] [Abstract][Full Text] [Related]
17. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
[TBL] [Abstract][Full Text] [Related]
18. RUNX2: A Master Bone Growth Regulator That May Be Involved in the DNA Damage Response.
Wysokinski D; Pawlowska E; Blasiak J
DNA Cell Biol; 2015 May; 34(5):305-15. PubMed ID: 25555110
[TBL] [Abstract][Full Text] [Related]
19. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
[TBL] [Abstract][Full Text] [Related]
20. Human estrogen receptor alpha gene is a target of Runx2 transcription factor in osteoblasts.
Lambertini E; Penolazzi L; Tavanti E; Schincaglia GP; Zennaro M; Gambari R; Piva R
Exp Cell Res; 2007 May; 313(8):1548-60. PubMed ID: 17350616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
